Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Intercell AG Announces Q3 2010 Results and Updates on R & D Progress and Management

November 8, 2010 By Bio-Medicine.Org

VIENNA, Nov. 9, 2010 /PRNewswire-FirstCall/ — Today, Intercell
AG (VSE: ICLL) announced its financial results for the third
quarter of 2010 and presented an update on the Company’s key
R&D programs as well as changes to the Management Board.

Financial Results

IXIARO and JESPECT sales revenues continue showing significant
year-on-year growth – sales revenues totaled EUR 9.4m in the
9 months ended September 30, 2010, compared to EUR 5.6m in the same
period of the previous year. Intercell’s aggregate revenues
decreased by 28.4% from EUR 29.5m in the 9 months ended
September 30, 2009 to EUR 21.1m in the same period of 2010.
Net loss for the first nine months of 2010 increased to EUR 50.9m
mainly driven by increased R&D expenses for late stage
development programs and non-cash currency effects. Solid cash
position with EUR 107.1m. Outlook full year 2010: Net loss for the
full year 2010 expected to reach approximately EUR 40.0m, at the
high end of previously communicated range, and this assumes
positive outcome of upcoming milestone events.

Key Financial FiguresEUR in thousands

3 months ended

9 months ended

Year endedSept 30,

2010Sept 30,

2009

Sept 30,

2010Sept 30,

2009

Dec 31,

2009Revenues

6,7049,159

21,11829,480

61,681Net profit/(loss)

(27,844)(14,671)

(50,892)(25,925)

(18,375)Net operating cash flow

(22,724)(14,753)

(49,218)(43,322)

(25,995)Cash and available-for-sale financial assets, end of
period

107,141139,746

107,141139,746

180,019IXIARO®/JESPECT®Intercell reports that the
positive trend of increasing sales of IXIARO/JESPECT seen in Q2
2010 continued in Q3. Intercell’s product is the only vaccine
against Japanese Encephalitis licensed in Europe. It is
manufactured for, and supplied into, the U.S., EU and Canada and
the only

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech